EICHORCondition: Amyotrophic Lateral Sclerosis · Sponsor: University Hospital, Limoges
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease. Studies have shown the importance of weight loss at the time of diagnosis and during the progression of the disease. However, the pathophysiological mechanisms behind weight loss remain unknown. Identifying these mechanisms could make it possible to propose an effective therapeutic strategy against weight loss for ALS patients, which could improve their survival and quality of life. In this context, the investigators are proposing an innovative multidisciplinary project aimed at structuring a large Franco-German cohort to identify the markers associated with weight loss in ALS. Participants will undergo high quality standard care for ALS patients. In addition, participants will be asked to respond different questionnaires and blood samples will be taken for analysis to identify biological markers.
This description comes directly from the study's public registry record.
Philippe COURATIER, Pr · 05 55 05 15 69 · philippe.couratier@chu-limoges.fr
Andrea ERAZO ALEMAN, Dr · DaniellsAndrea.ERAZOALEMAN@chu-limoges.fr
Always discuss trial participation with your own doctor first.
| CHU de Lille | Lille, France | Recruiting |
| Limoges University Hospital | Limoges, France | Recruiting |
| Hôpital de la Timone | Marseille, France | Recruiting |
| Hôpital Gui Chauliac | Montpellier, France | Recruiting |
| CHU de Nice | Nice, France | Recruiting |
| Hôpital de la Pitié Salpêtrière | Paris, France | Recruiting |
| CHU de Tours | Tours, France | Recruiting |
| Klinik für Medizinische Hochschule Hannover Carl-Neuberg-Str. 1 | Hanover, Allemagne, Germany | Not Yet Recruiting |
| Klinik für Neurologie, Universitäts- und Rehabilitationskliniken Ulm (RKU | Ulm, Allemagne, Germany | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06147843